2018 ESC/ESH Guidelines for the management of arterial hypertension
Рекомендации ESC/ESH 2018 года по лечению артериальной гипертензии
2018-08-25
SCID: 54.1/qqg2e54d
Discuss with AI
ESC/ESH Guidelinesarterial hypertensionclinical practice guidelineshypertension managementsystemic hypertension
Figures from the paper
Abstract (AI)
The current background information and detailed discussion of the data can be found in ESC CardioMed - Section 44 Systemic hypertension ... ... Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of guidelines have been issued in recent years by the European Society of Cardiology (ESC) and by the European Society of Hypertension (ESH), as well as by other societies and organisations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC website (http://www.escardio.org/Guidelines-&-Education/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines). ESC Guidelines represent the official position of the ESC on a given topic and are regularly updated.
Key Findings
1
Recommendations are intended to support clinical decision-making while preserving the responsible clinician’s and patient’s roles in final treatment decisions.
2
The 2018 ESC/ESH document provides evidence-based guidelines for managing arterial hypertension.
3
The document represents the official ESC position on arterial hypertension and is subject to regular updating.
4
The guidelines aim to help healthcare professionals select individualized management strategies for patients with hypertension.
5
The guidelines emphasize transparent development and evaluation of available evidence according to established quality criteria.
Research Object
Clinical practice guidelines for the management of arterial hypertension (2018 ESC/ESH Guidelines)
Research Subject
evidence-based management strategies and clinical decision-making for individual patients
Publication Details
Publication Date
2018-08-25
Journal
Publisher
ISSN
Cited by
11072
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai19
2013 ESH/ESC Guidelines for the management of arterial hypertension2013
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes2015
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2016
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)2012
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes2017
Guidelines for the Early Management of Patients With Acute Ischemic Stroke2013
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes2016
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes2016
2016 European Guidelines on cardiovascular disease prevention in clinical practice2016
A Randomized Trial of Intensive versus Standard Blood-Pressure Control2015
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet2013
2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)2017
2003 European Society of Hypertension???European Society of Cardiology guidelines for the management of arterial hypertension*2003
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy2018
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis2006
EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries2015
The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials2009
Cited by13
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2021
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)2020
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD2019
2020 ESC Guidelines for the management of adult congenital heart disease2020
2021 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure2022
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease2020
Global epidemiology, health burden and effective interventions for elevated blood pressure and hypertension2021
Measurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association2019
Secondary prevention through comprehensive cardiovascular rehabilitation: From knowledge to implementation. 2020 update. A position paper from the Secondary Prevention and Rehabilitation Section of the European Association of Preventive Cardiology2020
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice2021
Ten things to know about ten cardiovascular disease risk factors – 20222022
Prevalence, awareness, treatment, and control rates of hypertension in the general population of Australia: a systematic review and meta-analysis2024